06-11-2018 02:27 PM CET - Advertising, Media Consulting, Marketing Research
Print

Injection Pen Market Introducing Technological Advancements in the Injection Pens by Top Competitors Pfizer, Haselmeier, Biocon, Wockhardt Ltd., Jiangsu Delfu Co., DuPon and Forecast to 2025

Press release from: Data Bridge Market Research
Global Injection Pen Market
Global Injection Pen Market


Global Injection Pen Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of injection pen for global, Europe, North America, Asia Pacific and South America.

Get Free Sample Report: databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Injection Pen Market is expected to reach USD 49.92 billion by 2025, from USD 31.25 billion in 2017, growing at a CAGR of 6.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Major Market Drivers and Restraints:

• Technological advancements in the injection pens
Product launch and approval of accessories
• Prevalence of diabetes worldwide
• Government support and better reimbursement policies

Major Market Competitors/Players: Global Injection Pen Market

Some of the major players operating in the global injection pen market are:-
• Novo Nordisk,
• Sanofi,
• ELI Lilly and Company,
• Merck,
• Ypsomed,
• Astrazeneca,
• F.Hoffman-La Roche,
• Becton,
• Dickinson and Company (BD),
• Owen Mumford,
• Novartis,
• Pfizer,
• Haselmeier,
• Biocon,
• Wockhardt Ltd.,
• Jiangsu Delfu Co.,
• DuPont,
• Companion Medical,
• Unimould,
• BioCorp,
• Ulticare,
• B. Braun Melsungen AG,
• Terumo Corporation,
• Allison Medical,
• Cambridge Sensors Ltd.,
• Montmed Inc.,
• Stat Medical Inc.,
• Companion Medical,
• DIAMESCO,
• Emperra GmbH.,

Inquiry Before Buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Definition: Global Injection Pen Market

This market report defines the market trends and forecast the upcoming opportunities and threats of the injection pen market in the next 8 years. Injection pen is a small, hand held portable device used to inject insulin for the treatment of diabetes. The device is designed to deliver the drug in the body with the ease and convenience. Prevalence of diabetes is driving the market. According to American Diabetes Association (ADA), in 2015, 30.3 million or 9.4% Americans of the total population had diabetes. The ADA reports that about 1.5 million Americans are diagnosed with diabetes every year. According to WHO, the diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation and reports that 1.6 million deaths were directly caused by diabetes.. The increase in prevalence of diabetes raises the demands for early detection of the diabetes which leads to and the need for technological advancements in the injectable pens, for instance, in 2017 Sanofi launched AllStar pro reusable pen injector in market across Europe. The product is used by the diabetic patients. It uses replaceable cartridges, providing a convenient option for patients who inject regular doses of insulin. In 2017, Becton, Dickinson and Company launched the BD Ultra-Fine Micro 6mm needle, to provide a wide variety of needle lengths for people with diabetes. The product is designed to optimize comfort to the users. The product enables pediatric, adults and obese patients to inject into the fat layer, to avoid intramuscular (IM) injections.

Market Segmentation: Global Injection Pen Market

• The global injection pen market is segmented on the basis of type, therapy, distribution channels and end user.
• On the basis of type, the global injection pen market is segmented into disposable and reusable.
• On the basis of therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other. Diabetes is further sub segmented into insulin and glucagon-like peptide-1 (GLP-1).
• On the basis of end user the global injection pen market is segmented into home care and hospitals & clinics.
• On the basis of distribution channel the global injection pen market is segmented into retail pharmacies, hospital pharmacies, online methods and diabetes clinics & centers.
• Based on geography, the global injection pen market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.
Access Full Report: databridgemarketresearch.com/reports/global-injection-pen...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1077525 • Views: 448
More releasesMore releases

You can edit or delete your press release here: